These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21432579)

  • 21. [Validity and reliability of the Turkish version of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults].
    Oncü B; Olmez S; Sentürk V
    Turk Psikiyatri Derg; 2005; 16(4):252-9. PubMed ID: 16362844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of the Conners' Adult ADHD Rating Scale validity scales in identifying simulated attention-deficit hyperactivity disorder and random responding.
    Walls BD; Wallace ER; Brothers SL; Berry DTR
    Psychol Assess; 2017 Dec; 29(12):1437-1446. PubMed ID: 29227125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminating among ADHD alone, ADHD with a comorbid psychological disorder, and feigned ADHD in a college sample.
    Williamson KD; Combs HL; Berry DT; Harp JP; Mason LH; Edmundson M
    Clin Neuropsychol; 2014; 28(7):1182-96. PubMed ID: 25225947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and diagnostic utility of self-report attention deficit hyperactivity disorder scales in adults.
    McCann BS; Roy-Byrne P
    Compr Psychiatry; 2004; 45(3):175-83. PubMed ID: 15124147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of feigned attention deficit hyperactivity disorder.
    Tucha L; Fuermaier AB; Koerts J; Groen Y; Thome J
    J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S123-34. PubMed ID: 25096370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Utility of the Wender-Utah rating scale and the checklists for the diagnosis of familial attention deficit hyperactivity disorder in adults. Convergent and concurrent validities].
    Pineda DA; Trujillo-Orrego N; Aguirre-Acevedo DC; Arango CP; Hincapié-Henao L; Montoya-Arenas DA; Lopera F; Pineda-Alvarez DE; Arcos-Burgos M; Muenke M
    Rev Neurol; 2010 Feb 16-28; 50(4):207-16. PubMed ID: 20198592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intentional inattention: Detecting feigned attention-deficit/hyperactivity disorder on the Personality Assessment Inventory.
    Smith ST; Cox J; Mowle EN; Edens JF
    Psychol Assess; 2017 Dec; 29(12):1447-1457. PubMed ID: 29227126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory tests in subgroups of adult attention deficit hyperactivity disorder reveals simultaneous capacity deficit.
    Dige N; Maahr E; Backenroth-Ohsako G
    Int J Neurosci; 2008 Apr; 118(4):569-91. PubMed ID: 18322864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are pervasive developmental disorders and attention-deficit/hyperactivity disorder distinct disorders?
    Hattori J; Ogino T; Abiru K; Nakano K; Oka M; Ohtsuka Y
    Brain Dev; 2006 Jul; 28(6):371-4. PubMed ID: 16504439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder.
    Weiss MD; Gibbins C; Goodman DW; Hodgkins PS; Landgraf JM; Faraone SV
    J Clin Psychiatry; 2010 Apr; 71(4):381-90. PubMed ID: 20361900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11.
    Todd RD; Huang H; Henderson CA
    J Child Psychol Psychiatry; 2008 Sep; 49(9):942-9. PubMed ID: 18564071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of feigned cognitive dysfunction using special malinger tests: a simulation study in naïve and coached malingerers.
    Jelicic M; Merckelbach H; Candel I; Geraerts E
    Int J Neurosci; 2007 Aug; 117(8):1185-92. PubMed ID: 17613120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students.
    Heiligenstein E; Conyers LM; Berns AR; Miller MA
    J Am Coll Health; 1998 Jan; 46(4):185-8. PubMed ID: 9519582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders.
    Barnett R; Maruff P; Vance A
    Aust N Z J Psychiatry; 2009 Aug; 43(8):722-30. PubMed ID: 19629793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Validation of the Spanish version of the attention deficit hyperactivity disorder adult screening scale (ASRS v. 1.1): a novel scoring strategy].
    Ramos-Quiroga JA; Daigre C; Valero S; Bosch R; Gómez-Barros N; Nogueira M; Palomar G; Roncero C; Casas M
    Rev Neurol; 2009 May 1-15; 48(9):449-52. PubMed ID: 19396760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
    Adler LA; Liebowitz M; Kronenberger W; Qiao M; Rubin R; Hollandbeck M; Deldar A; Schuh K; Durell T
    Depress Anxiety; 2009; 26(3):212-21. PubMed ID: 19194995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of self-regulation and inhibition in children exhibiting attention deficit disorder with or without hyperactivity (ADHD)].
    Poissant H; Neault I; Dallaire S; Rouillard M; Emond V; Guay MC; Lageix P
    Encephale; 2008 Apr; 34(2):161-9. PubMed ID: 18597724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
    Newcorn JH; Spencer TJ; Biederman J; Milton DR; Michelson D
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):240-8. PubMed ID: 15725968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
    Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.